- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Growth Potential Companies
Swedish Pharmaceuticals & Biotech High Growth Potential Companies
Results
29
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SCOL | SEK 0.13 | -14.6% | -92.2% | SEK 29.9m | n/a | PB0.6x | E75.3% | n/a | ||
NEWBRY | SEK 3.26 | 5.2% | -15.3% | SEK 79.1m | SEK 8.00 | PS4.3x | E116.2% | n/a | ||
CALTX | SEK 206.20 | -0.6% | 130.8% | SEK 11.1b | SEK 227.50 | PS7x | E51.9% | n/a | ||
CAMX | SEK 687.50 | 2.1% | 136.7% | SEK 40.3b | SEK 742.67 | PE180.6x | E75.0% | n/a | ||
XBRANE | SEK 0.14 | 8.2% | -99.5% | SEK 218.1m | n/a | PS1.1x | E118.0% | n/a | ||
MAGLE | SEK 37.80 | 0.5% | 18.9% | SEK 408.2m | SEK 50.00 | PE53.1x | E72.2% | n/a | ||
BONEX | SEK 313.00 | 8.4% | 151.0% | SEK 20.6b | SEK 323.33 | PE71.3x | E31.2% | n/a | ||
BIOA B | SEK 174.50 | -4.1% | -43.5% | SEK 15.4b | SEK 290.60 | PS51.5x | E98.4% | 0% | ||
BIOVIC B | SEK 2.62 | 0.8% | -60.1% | SEK 220.3m | SEK 6.20 | PS29.7x | E78.5% | n/a | ||
IMMU | SEK 7.87 | -10.8% | -11.4% | SEK 396.4m | SEK 36.00 | PS12.5x | E104.6% | n/a | ||
XSPRAY | SEK 47.00 | -6.4% | -3.5% | SEK 1.6b | SEK 76.00 | PB2.4x | E122.4% | n/a | ||
CLBIO | SEK 8.38 | -10.9% | -49.8% | SEK 180.1m | SEK 25.00 | PS6.2x | E134.3% | n/a | ||
KAN | SEK 1.93 | -11.3% | -61.6% | SEK 234.4m | SEK 3.10 | PB2.8x | E77.1% | n/a | ||
LPGO | SEK 0.25 | -1.6% | -67.0% | SEK 37.1m | SEK 1.60 | PS4x | E116.3% | n/a | ||
SENZA | SEK 7.45 | -0.7% | -9.6% | SEK 219.8m | SEK 16.00 | PS4x | E109.9% | n/a | ||
KLAR | SEK 0.74 | 51.0% | 28.5% | SEK 96.0m | SEK 1.00 | PB4.6x | E57.8% | n/a | ||
DVYSR | SEK 115.50 | 1.3% | 71.9% | SEK 1.9b | SEK 128.66 | PS9.7x | E109.0% | n/a | ||
EGTX | SEK 5.25 | -6.4% | 19.7% | SEK 1.5b | SEK 11.40 | PS21.7x | E90.0% | n/a | ||
BINV | SEK 43.10 | 9.8% | 157.5% | SEK 2.8b | SEK 90.00 | PS53.8x | E102.7% | n/a | ||
RLS | SEK 0.45 | -0.2% | -84.2% | SEK 35.6m | SEK 7.00 | PS33.1x | E92.8% | n/a | ||
ALIF B | SEK 163.30 | 2.9% | 138.2% | SEK 19.9b | SEK 168.00 | PE168.6x | E55.2% | 0.3% | ||
ORX | SEK 15.02 | 0.9% | -14.2% | SEK 518.3m | SEK 21.50 | PB21.4x | E74.3% | n/a | ||
VITR | SEK 251.00 | -0.8% | 73.0% | SEK 34.0b | SEK 261.67 | PS9.6x | E105.8% | 0.4% | ||
GENO | SEK 22.85 | -2.6% | -54.3% | SEK 1.5b | SEK 43.00 | PE86.7x | E28.8% | n/a |